Chargement en cours...
Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
SIMPLE SUMMARY: Despite remarkable progress in the outcome of childhood acute myeloid leukemia (AML), risk of relapse and refractory diseases remains high. Treatment of the chemo-refractory disease is restricted by dose-limiting therapy-related toxicities which necessitate alternative tolerable effi...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003817/ https://ncbi.nlm.nih.gov/pubmed/33804676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061423 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|